Member Info for FreeTheCaterham7

BJW said - "the MAB's will need to be re-purposed/updated as they were for previous mutations of covid"
GSK's Sotrovimab (sp?) seems to be pretty variant agnostic. That's what they claim anyway.

"These final trial surely must show it works but why isn’t the UK government out for it?"
Well the P3 trial might show that it works, indeed probably will, but it might not.
That's why you do the trial.
I don't think the govt can get too excited about it - at least not in public - until P3 has proved the efficacy of SNG001

No need to call people names

@antharry
I geddit

Underrated comment

Hope you’re not invested….in anything.

"but I am banking on +£3.50 arriving as a spike affording an exit ahead of results as the shoot or bust money arrives."

I don't see why you'd bank on that

If the shares are certificated in your own name I don’t think you’d have a problem with your broker lending them, because he can’t.

Think you are adding 2+2 and making 12,428,914.097

Think you are adding 2+2 and making 12,428,914.097

I don't pay much attention to Morningstar because it's so out of date and misses so many holdings, but that holding indication is explicitly of a long position.

Ivor
How could that possibly be a short?

Shorts over 0.1% have to be declared to the FCA
https://www.fca.org.uk/markets/short-selling/notification-and-disclosure-net-short-positions

Shorttracker https://shorttracker.co.uk/company/GB00B11DNM70/ is the easiest place to see the info

"keeping shares at hand to raise money (we hope from existing or new institutional investors) in an unforeseen scenario like the stope collapse"

What does this mean?

"Today was manipulation, much as the likes of freethecaterham would hate to admit it…"
Manipulation schmanipulation.

"This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No. 596/2014 ('MAR')"

This is a catch-all disclaimer that refers to the RNS itself, not the presentation. It absolutely doesn't mean that there is going to be market moving new info revealed at the presentation.

Thanks BG

Although as Welsh Falcon points out, efficacy against viral infections in asthma and COPD is not to be sneezed at. Or coughed at. So good news on that front could be v. positive.

Nothing in the RNS to get too excited about.
Open to correction as always but why would they highlight in vitro studies vs a, ß, and ? variants without info on d? Have they not tested SNG001 in vitro vs d?

Why would they be highlighting efficacy against viral infection in patients with asthma and COPD when what everyone wants to here about is efficacy vs Covid? Although I guess the answer to that one might be that they have proper studies vs asthma and COPD and are still awaiting the data on Covid.

Poorly phrased.
This might be better
The link in Xviolet’s post seems to say that that the rise in Covid hospital cases is largely because a higher proportion of those admitted to hospital for other reasons turn out to have Covid.

Xviolet's post looks like it says hospital admissions with Covid are going up, but that's just because a higher proportion of people who are admitted for other reasons turn out to have covid
"SARS-CoV-2 has been an incidental finding in patients that were admitted to the hospital for another medical, surgical or obstetric reason."